Literature DB >> 11745817

Liver resection for hepatocellular carcinoma in patients with end-stage renal failure.

S B Cheng1, C C Wu, K H Shu, W L Ho, J T Chen, D C Yeh, T J Liu, F K P'eng.   

Abstract

BACKGROUND AND OBJECTIVES: Surgical resection remains the main option for curing hepatocellular carcinoma (HCC). However, liver resection in patients with end-stage renal disease (ESRD) is risky. The aim of this study is to clarify the role of liver resection for treating HCC in patients with ESRD.
METHODS: A retrospective review was carried out on 468 patients who underwent liver resection for HCC between 1989 and 1999. The clinicopathological characteristics and operative results of 12 patients who had ESRD (ESRD group) were compared with those of the other 456 patients who did not have ESRD (non-ESRD group). In the ESRD group, heparin-free hemodialysis using the periodic saline-rinse method was performed during the perioperative period.
RESULTS: The ESRD group had lower hemoglobin and a higher serum creatinine levels. Other patient background and tumor pathological characteristics were comparable between the two groups as well. The operative morbidity and mortality between the two groups were also similar. The 5-year disease-free survival rates for ESRD and non-ESRD groups were 35.0 and 34.2% (P = 0.31), respectively, while the 5-year actuarial survival rates were 67.8 and 53.3% (P = 0.54), respectively.
CONCLUSION: With improving techniques and knowledge of dialysis, liver resection for HCC is justified in selected patients with ESRD. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11745817     DOI: 10.1002/jso.1160

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  16 in total

1.  Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.

Authors:  Chun-Nan Yeh; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure.

Authors:  Takashi Orii; Tetsuro Takayama; Izumi Haga; Tatsuya Fukumori; Noritoshi Amada
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

3.  Hepatectomy in patients with nonuremic minimal renal failure.

Authors:  Tokihiko Sawada; Junji Kita; Kyu Rokkaku; Masato Kato; Mitsugi Shimoda; Keiichi Kubota
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

4.  Prognosis of hepatocellular carcinoma after hepatectomy in patients with renal dysfunction.

Authors:  Masaki Kaibori; Yoichi Matsui; A-Hon Kwon; Toshiko Tokoro; Yasuo Kamiyama
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis.

Authors:  Andrew S Barbas; Paul J Speicher; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2014-06-16       Impact factor: 3.647

6.  Hepatocellular carcinoma in patients with chronic kidney disease.

Authors:  Chern-Horng Lee; Sen-Yung Hsieh; Ja-Liang Lin; Maw-Sen Liu; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

7.  Hepatic resection for hepatocellular carcinoma patients on hemodialysis for uremia: a nationwide cohort study.

Authors:  Chun-Chieh Yeh; Jaw-Town Lin; Long-Bin Jeng; Iakovidis Charalampos; Tzu-Ting Chen; Teng-Yu Lee; Ming-Shiang Wu; Ken N Kuo; Yi-Ya Liu; Chun-Ying Wu
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

8.  Pylorus-preserving pancreaticoduodenectomy in patients undergoing chronic hemodialysis.

Authors:  Hiroki Uchida; Kohei Shibata; Seiichiro Kai; Kentaro Iwaki; Masayuki Ohta; Seigo Kitano
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

9.  Association of dialysis with adverse postoperative outcomes in colorectal cancer-an analysis of ACS-NSQIP.

Authors:  Wan-Hsiang Hu; Luis Carlos Cajas-Monson; Samuel Eisenstein; Lisa Parry; Sonia Ramamoorthy
Journal:  Int J Colorectal Dis       Date:  2015-08-05       Impact factor: 2.571

10.  ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy.

Authors:  Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Chih-Chieh Ko; Yi-Hsiang Huang; Chien-Wei Su; Cheng-Yuan Hsia; Rheun-Chuan Lee; Ming-Chih Hou; Teh-Ia Huo
Journal:  J Gastrointest Oncol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.